UnitedHealth Group Incorporated (UNH)
NYSE: UNH · Real-Time Price · USD
590.87
-6.62 (-1.11%)
Nov 22, 2024, 4:00 PM EST - Market closed
UnitedHealth Group Stock Forecast
Stock Price Forecast
The 19 analysts with 12-month price forecasts for UnitedHealth Group stock have an average target of 606.32, with a low estimate of 460 and a high estimate of 650. The average target predicts an increase of 2.61% from the current stock price of 590.87.
Analyst Consensus: Strong Buy
* Price targets were last updated on Oct 22, 2024.
Analyst Ratings
The average analyst rating for UNH stock from 20 stock analysts is "Strong Buy". This means that analysts believe this stock is likely to perform very well in the near future and significantly outperform the market.
Recommendation Trends
Rating | Jun '24 | Jul '24 | Aug '24 | Sep '24 | Oct '24 | Nov '24 |
---|---|---|---|---|---|---|
Strong Buy | 6 | 7 | 7 | 7 | 7 | 7 |
Buy | 13 | 10 | 10 | 10 | 11 | 11 |
Hold | 4 | 3 | 3 | 2 | 2 | 2 |
Sell | 0 | 0 | 0 | 0 | 0 | 0 |
Strong Sell | 0 | 0 | 0 | 0 | 0 | 0 |
Total | 23 | 20 | 20 | 19 | 20 | 20 |
Latest Forecasts
Analyst | Firm | Rating | Rating | Action | Price Target | Upside | Date |
---|---|---|---|---|---|---|---|
Barclays | Barclays | Buy Maintains $604 → $603 | Buy | Maintains | $604 → $603 | +2.05% | Oct 22, 2024 |
TD Cowen | TD Cowen | Strong Buy Maintains $601 → $609 | Strong Buy | Maintains | $601 → $609 | +3.07% | Oct 18, 2024 |
UBS | UBS | Strong Buy Maintains $680 → $650 | Strong Buy | Maintains | $680 → $650 | +10.01% | Oct 16, 2024 |
Stephens & Co. | Stephens & Co. | Buy Maintains $632 → $605 | Buy | Maintains | $632 → $605 | +2.39% | Oct 16, 2024 |
Cantor Fitzgerald | Cantor Fitzgerald | Buy Maintains $591 → $644 | Buy | Maintains | $591 → $644 | +8.99% | Oct 16, 2024 |
Financial Forecast
Revenue This Year
404.78B
Revenue Next Year
435.73B
from 404.78B
Increased by 7.65%
EPS This Year
27.89
from 23.86
Increased by 16.89%
EPS Next Year
30.20
from 27.89
Increased by 8.29%
Revenue Forecast
Revenue | 2024 | 2025 | 2026 | 2027 | 2028 |
---|---|---|---|---|---|
High | 423.8B | 466.9B | 510.0B | ||
Avg | 404.8B | 435.7B | 469.1B | ||
Low | 389.7B | 413.6B | 438.6B |
Revenue Growth
Revenue Growth | 2024 | 2025 | 2026 | 2027 | 2028 |
---|---|---|---|---|---|
High | - | 15.3% | 17.0% | ||
Avg | - | 7.6% | 7.7% | ||
Low | - | 2.2% | 0.7% |
EPS Forecast
EPS | 2024 | 2025 | 2026 | 2027 | 2028 |
---|---|---|---|---|---|
High | 29.14 | 32.50 | 36.78 | ||
Avg | 27.89 | 30.20 | 33.99 | ||
Low | 26.76 | 28.67 | 31.76 |
EPS Growth
EPS Growth | 2024 | 2025 | 2026 | 2027 | 2028 |
---|---|---|---|---|---|
High | 22.1% | 16.5% | 21.8% | ||
Avg | 16.9% | 8.3% | 12.5% | ||
Low | 12.2% | 2.8% | 5.2% |
Sources: Price targets and analyst ratings provided by Benzinga. Revenue and EPS forecast data provided by Finnhub. The data is sourced from Wall Street analysts. Data disclaimer.